Front market [stocks that have moved, stocks that have been created]

*Teijin ＜3401＞ 1573 +168 Oasis Japan has emerged as a major shareholder. *Ibiden ＜4062＞ 5842 +445 has a buying advantage as a semiconductor stock related to NVIDIA. *DISCO＜6146＞ 61600 +3930 US NVIDIA announced better financial results than expected. *Menicon ＜7780＞ 1367.5 +78.5 Ichiyoshi Securities raised its rating. *TOWA ＜6315＞ 14320 +780 related to generated AI similar to disco

Fisco Japan54minutes ago

Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/22)

[Good Material] ――――――――――■Daiseki Environmental Solutions [Tokyo Stock Exchange S] will carry out a share buyback of up to 40,000 shares (46 million yen in value), which is 0.23% of the number of issued shares (excluding company shares). The purchase period is from 5/23 to 6/11. ■Patent assessments have been obtained in the United States for unique technologies that solve natural language processing issues, such as FRONTEO [Tokyo Stock Exchange G] LLM (large-scale language model). ■Delivery Hall

MinkabuMay 22 07:00 ET

Last Mile, Netyear, etc.

＜3542＞VEGA upward revision, previous fiscal year operating profit forecast 770 million yen ← 660 million yen ＜3622＞net year upward revision, previous fiscal year operating profit forecast 144 million yen ← 0.3 billion yen ＜3905＞ data section concluding a basic agreement for a business alliance with Supermicro (US) ＜3917＞capital and business alliance with iRidge Dip ＜2379＞ New stock issuance through third party allotment (358,400 shares) ＜3967＞Eltes shareholder benefit plan “Eltes Premier

Fisco JapanApr 14 18:30 ET

Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen

Astellas Pharmaceuticals ＜4503＞ announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] ＜8233＞Takashimaya Full Year | ＜6432＞Takeuchi Production

Fisco JapanApr 14 17:23 ET

Bic Camera, Money Forward, Ryohin Keikaku, Takashimaya (12 days)

*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/12 (Fri) ＜1401＞mbs ＜1407＞West HD＜1418＞Interlife ＜1434＞JESCOHD＜2153＞Ejay HD ＜2168＞Pasona G＜2305＞Studio Alice ＜2379＞dip

Fisco JapanApr 11 17:30 ET

FFRI, NPC, etc. [Emerging Markets Press Release]

＜3692＞FFRI upward revision, first-year operating profit forecast 496 million yen ← 261 million yen ＜4438＞Welby acquires shares in medical data cards that handle planning, development, and provision of internet mobile cloud services to centrally manage health/medical information and makes them a subsidiary ＜4579＞LaQualia Pharmaceutical America Syros Inc. has designated Tamibaroten as a fast-track target for acute myeloid leukemia (AML) in the US Tell me what I received from the FDA

Fisco JapanApr 10 18:30 ET